Skip to content
Nonprofiteer
← THE NASPGHAN FOUNDATION

Form 990 for tax year 2022

Filed by THE NASPGHAN FOUNDATION.

Totals

Total revenue
$1,995,391
Total expenses
$1,511,688
Contributions and grants received
$1,904,598
Grants paid
$834,019
Program service revenue
$0
Investment income
$90,793
Other revenue
$0
Total assets, end of year
$6,677,645
Total liabilities, end of year
$1,431,689
Net assets or fund balances, end of year
$5,245,956
Program services expenses (Part IX)
$1,328,861
Management and general expenses
$155,607
Fundraising expenses
$27,220
Program service expenses (Part III)
$1,328,861

Program services were 87.9% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.

Line items

Every line the filer filed in Parts VIII, IX and X, as filed and in filed order. Blank columns are left out, and the lines are not forced to add up to the totals above.

Revenue

Part VIII, the statement of revenue.

  • 1b · Membership dues

    $250,000

  • 1f · All other contributions, gifts and grants

    $1,654,598

  • 3 · Investment income

    total $104,663 · excluded $104,663

  • 7a · Gross sales of assets other than inventory

    securities $413,718

  • 7b · Less cost or other basis and sales expenses

    securities $427,588

  • 7c · Gain or loss

    securities -$13,870

  • 7d · Net gain or loss

    total -$13,870 · excluded -$13,870

Functional expenses

Part IX, the statement of functional expenses.

  • 1 · Grants to domestic organizations and governments

    total $15,000 · program services $15,000

  • 2 · Grants to domestic individuals

    total $819,019 · program services $819,019

  • 6 · Compensation of disqualified persons

    total $50,000 · program services $32,955 · management and general $11,365 · fundraising $5,680

  • 7 · Other salaries and wages

    total $37,996 · program services $25,043 · management and general $8,637 · fundraising $4,316

  • 11f · Fees: investment management

    total $23,093 · management and general $23,093

  • 11g · Fees: other

    total $35,273 · program services $7,679 · management and general $13,393 · fundraising $14,201

  • 16 · Occupancy

    total $22,483 · program services $15,739 · management and general $4,496 · fundraising $2,248

  • 17 · Travel

    total $2,683 · program services $1,879 · management and general $536 · fundraising $268

  • 23 · Insurance

    total $3,243 · program services $2,271 · management and general $648 · fundraising $324

  • 24a · Other expenses: EDUCATION MATERIALS

    total $397,430 · program services $397,430

  • 24b · Other expenses: MISCELLANEOUS EXPENSES

    total $91,981 · management and general $91,981

  • 24c · Other expenses: GRANT ADMINISTRATION

    total $10,561 · program services $10,561

  • 24d · Other expenses: PRINTING

    total $1,835 · program services $1,285 · management and general $367 · fundraising $183

  • 24e · All other expenses

    total $1,091 · management and general $1,091

Balance sheet

Part X, book values.

  • 1 · Cash, non-interest-bearing

    beginning of year $1,315,220 · end of year $2,190,999

  • 2 · Savings and temporary cash investments

    beginning of year $669,348 · end of year $352,860

  • 3 · Pledges and grants receivable

    beginning of year $374,500 · end of year $115,001

  • 4 · Accounts receivable

    end of year $29,738

  • 9 · Prepaid expenses and deferred charges

    beginning of year $11,191 · end of year $12,756

  • 11 · Investments: publicly traded securities

    beginning of year $4,152,521 · end of year $3,976,291

  • 17 · Accounts payable and accrued expenses

    beginning of year $95,434 · end of year $95,689

  • 18 · Grants payable

    beginning of year $1,095,000 · end of year $1,286,000

  • 19 · Deferred revenue

    beginning of year $10,000 · end of year $50,000

  • 27 · Net assets without donor restrictions

    beginning of year $1,713,422 · end of year $2,085,087

  • 28 · Net assets with donor restrictions

    beginning of year $3,608,924 · end of year $3,160,869

Mission and programs · 2022

Mission

THE NASPGHAN FOUNDATION FUNDS AND SUPPORTS THE RESEARCH AND EDUCATION MISSIONS OF NASPGHAN IN ORDER TO ENHANCE THE HEALTH AND WELL-BEING OF CHILDREN WITH GASTROINTESTINAL, LIVER, PANCREAS AND NUTRITIONAL DISORDERS.

Activities or mission (Part I)

FUNDS & SUPPORTS RESEARCH AND EDUCATION MISSIONS OF NASPGHAN.

  • Withheld by Nonprofiteer: this text may name a private individual.

    Expenses $847,820 · Grants $834,019

  • EDUCATIONAL CAMPAIGNS:THE FOUNDATION SUPPORTS THE EDUCATIONAL MISSION OF NASPGHAN THROUGH ADIVERSE PORTFOLIO OF PROFESSIONAL AND PUBLIC EDUCATION INITIATIVES.TOPIC AREAS ARE REFLUX AND GERD, INFLAMMATORY BOWEL DISEASE, CELIACDISEASE AND GLUTEN-RELATED DISORDERS, CONSTIPATION, EOSINOPHILICESOPHAGITIS, NUTRITION, ENDOSCOPY, AND NONALCOHOLIC FATTY LIVER DISEASEIN CHILDREN, ADOLESCENTS AND YOUNG ADULTS. THE FOUNDATION'S GOAL IS TOEDUCATE MEDICAL PROFESSIONALS AND THE PUBLIC, AND TO SUPPORT THEDEVELOPMENT OF NEW RESEARCH IN THESE AREAS. THE PRIMARY OBJECTIVES ARETO IMPROVE THE QUALITY OF LIFE AND TO CHANGE PEDIATRIC AND ADULT HEALTHOUTCOMES BY EARLY DETECTION AND INTERVENTION.GIKIDS IS THE PATIENT OUTREACH AND EDUCATION EFFORT OF NASPGHAN. WITHGIKIDS, NASPGHAN AND THE FOUNDATION ARE WORKING TO REACH OUT DIRECTLYTO FAMILIES, KIDS AND TEENS WHO LIVE WITH DIGESTIVE CONDITIONS TOPROVIDE THEM WITH THE INFORMATION THEY NEED TO:-UNDERSTAND AND IMPROVE THEIR DIGESTIVE HEALTH-WORK WITH THEIR HEALTH CARE PROVIDERS-LIVE A MORE INDEPENDENT LIFE-UNDERSTAND WHAT WORKS IN PLAIN LANGUAGE"A PRACTICAL APPROACH TO NUTRITIONAL MANAGEMENT OF CHILDREN WITH CHOLESTATIC LIVER DISEASES: TIPS FOR PATIENTS AND CAREGIVERS" WEBINAR AND ON DEMAND PROGRAMCHILDREN WITH CHOLESTATIC LIVER DISEASES HAVE UNIQUE NUTRITIONAL REQUIREMENTS. OBJECTIVES: 1.OVERVIEW OF THE CLINICAL PRESENTATION AND LONG-TERM IMPLICATIONS OF MALNUTRITION AND FAT-SOLUBLE VITAMIN DEFICIENCIES IN CHILDREN WITH CHOLESTATIC LIVER DISORDERS.2.REVIEW CURRENT AVAILABLE FORMULATION AND PRACTICAL TIPS FOR THE CARE PROVIDER.3.REVIEW THE CURRENTLY AVAILABLE VITAMIN SUPPLEMENTS, FORMULATIONS AND DISCUSSION 4.DISCUSS LACK OF INSURANCE COVER FOR MEDICAL FOOD, VITAMINS AND FINANCIAL BURDEN TO THE FAMILIES.HEPATITIS C SLIDE SET AND GRAND ROUNDSHCV INFECTION IS CHILDREN IS FREQUENTLY UNRECOGNIZED. RECENTLY PROPOSED UNIVERSAL TESTING STRATEGIES DURING PREGNANCY NEED TO BE IMPLEMENTED. ALTHOUGH LIVER DISEASE IS GENERALLY MILD IN CHILDREN, CHRONIC HEPATITIS AND CIRRHOSIS OCCURS. DIRECT ACTIVE ANTIVIRALS ARE VERY EFFICACIOUS AND SAFE. THEREFORE, ALL HCV INFECTED CHILDREN > 3 YEARS OF AGE SHOULD BE CONSIDERED FOR TREATMENT. PUBLIC AND PROFESSIONAL EDUCATION IS CRITICALLY IMPORTANT TO INCREASE HCV AWARENESS. THE FOUNDATION DEVELOPED A SLIDE DECK AND GRAND ROUNDS PROGRAM TO INCREASE AWARENESS REGARDING TESTING AND MANAGEMENT OF HCV."NUTRITION AND LIVER DISEASE IN PEROXISOMAL BIOGENESIS DISORDERS: DIAGNOSIS AND MANAGEMENT" NASPGHAN NUTRITION UNIVERSITY (N2U)THIS COURSE IS DESIGNED TO PROVIDE SPECIALIZED NUTRITION EDUCATION INAREAS ASSOCIATED WITH THE PRACTICE OF PEDIATRIC GASTROENTEROLOGY ANDNUTRITION TO 3RD YEAR FELLOWS, JUNIOR FACULTY AND DIETITIANS. ITTARGETS TWO GROUPS: CANDIDATES WHO RECEIVED MINIMAL NUTRITION EDUCATIONDURING THEIR FELLOWSHIP OR WHOM PLAN TO PURSUE PEDIATRIC NUTRITION ASTHEIR CAREER FOCUS.TEACHING AND TOMORROW UNDERREPRESENTED IN MEDICINE (URIM) PROGRAMTHE PEDIATRIC GI TEACHING AND TOMORROW PROGRAM OF NASPGHAN STRIVES TO ATTRACT THE BRIGHTEST RESIDENTS TO SUBSPECIALTY TRAINING IN PEDIATRIC GASTROENTEROLOGY, HEPATOLOGY AND NUTRITION. DUE TO THE EXCELLENT INTEREST IN THIS INNOVATIVE NASPGHAN PROGRAM, WE HAVE SEEN CONTINUAL GROWTH IN THE INTEREST AND APPLICATIONS TO GI TRAINING PROGRAMS THROUGH THE YEARS. THIS PROGRAM HAS BEEN RECENTLY EXPANDED TO PROVIDE SCHOLARSHIPS TO INTERESTED 1ST AND 2ND YEAR PEDIATRIC RESIDENTS AND 4TH YEAR MEDICAL STUDENTS WHO SELF-IDENTIFY AS UNDERREPRESENTED IN MEDICINE (URIM). IN ADDITION TO NETWORKING WITH OTHER PARTICIPANTS WHILE ATTENDING THE PROGRAM'S SCHEDULED SESSIONS, THE URIM PROGRAM ATTENDEES ARE MATCHED UP WITH A NASPGHAN FELLOW AND/OR ATTENDING PHYSICIAN (A TEACHING AND TOMORROW PROGRAM ALUMNUS) WHO SERVES AS A POINT OF CONTACT AND AMBASSADOR TO THE ANNUAL MEETING. WE WERE ABLE TO SUPPORT 5 STUDENTS IN 2022 AND 17 IN 2023.URIM NASPGHAN/NASPGHAN FOUNDATION MEDICAL STUDENT MENTORED SUMMER RESEARCH PROGRAMTHE URIM NASPGHAN/NASPGHAN FOUNDATION MEDICAL STUDENT MENTORED SUMMER RESEARCH PROGRAM TAKES PLACE AT MULTIPLE SITES THROUGHOUT THE U.S. AND CANADA AND PROVIDES MEDICAL STUDENTS WHO SELF-IDENTIFY AS URIM WITH A 10-WEEK RESEARCH EXPERIENCE UNDER THE MENTORSHIP OF BASIC OR CLINICAL SCIENTISTS WITH A RESEARCH FOCUS IN PEDIATRIC GASTROENTEROLOGY, HEPATOLOGY, OR NUTRITION. CANDIDATES FOR THESE SCHOLARSHIPS MUST HAVE COMPLETED AT MINIMUM THEIR FIRST YEAR OF MEDICAL TRAINING AND BE IN GOOD STANDING AT ACCREDITED MEDICAL SCHOOLS IN THE U.S. AND CANADA. PREFERENCE IS GIVEN TO STUDENTS WHO ARE SEEKING A RESEARCH EXPERIENCE BETWEEN THE FIRST AND SECOND YEARS OF MEDICAL SCHOOL, THOUGH APPLICATIONS FROM ALL CURRENTLY ENROLLED STUDENTS ARE CONSIDERED. THESE STUDENTS ARE ALSO INVITED TO ATTEND THE ANNUAL MEETING, PRESENT A POSTER OF THEIR PROJECT AND PARTICIPATE IN THE TEACHING AND TOMORROW PROGRAM. WE WERE ABLE TO SUPPORT 4 STUDENTS IN 2022 AND 4 STUDENTS IN 2023.EDUCATIONTHE FOUNDATION SUPPORTS THE EDUCATIONAL MISSION OF NASPGHAN THROUGH A DIVERSE PORTFOLIO OF PROFESSIONAL AND PUBLIC EDUCATION INITIATIVES. THE FOUNDATION'S GOAL IS TO EDUCATE MEDICAL PROFESSIONALS AND THE PUBLIC, AND TO SUPPORT THE DEVELOPMENT OF NEW KNOWLEDGE THROUGH RESEARCH. THE PRIMARY OBJECTIVES ARE TO IMPROVE THE QUALITY OF LIFE AND TO IMPROVE HEALTH OUTCOMES THROUGH EDUCATION, EARLY DETECTION AND EVIDENCE-BASED CARE.EDUCATIONAL RESOURCES

    Expenses $481,041

  • WEBINARS AND ON-DEMAND EDUCATIONAL MODULESEGIDS: BEYOND THE ESOPHAGUSEGIDS ARE A COLLECTION OF CHRONIC INFLAMMATORY DISEASES INCLUDING EOSINOPHILIC ESOPHAGITIS (EOE), EOSINOPHILIC GASTRITIS (EG) EOSINOPHILIC GASTROENTERITIS (EGE), AND EOSINOPHILIC COLITIS (EC). AMONG THE EGIDS, EOE HAS BECOME AN INCREASINGLY RECOGNIZED AND STUDIED CONDITION. VALIDATED METRICS HAVE BEEN ESTABLISHED TO QUANTIFY QUALITY OF LIFE, SYMPTOMS, HISTOLOGIC AND ENDOSCOPIC FINDINGS. IN ADDITION, THERE ARE WELL-ESTABLISHED, EFFECTIVE TREATMENTS. THE SAME CANNOT BE SAID FOR EG, EGE, OR EC, WHICH LACKS WELL ESTABLISHED HISTOLOGIC CRITERIA FOR DIAGNOSIS, AND HAS A MORE UNCLEAR NATURAL HISTORY, NOR WELL-ESTABLISHED TREATMENTS. EGIDS: BEYOND THE ESOPHAGUS BRINGS TO LIGHT THE LATEST ON NON-EOE EGID, INCLUDING THE SIGNS AND SYMPTOMS; THE CRITERIA TO MAKE A DIAGNOSIS; WHAT OPTIONS EXIST FOR THERAPY, AND THE POTENTIAL MECHANISMS OF DISEASE. PRACTICAL TIPS IN THE NUTRITIONAL MANAGEMENT OF CHILDREN WITH CHOLESTATIC LIVER DISORDERS: A WEBINAR FOR PATIENTS, FAMILIES AND CAREGIVERSTHIS WEBINAR EXPLORES PRACTICAL APPROACHES TO THE NUTRITIONAL MANAGEMENT OF CHILDREN WITH CHOLESTATIC LIVER DISEASES, WITH SPECIAL TIPS FOR PATIENTS AND CAREGIVERS. PARTICIPANTS LEARN THE CLINICAL PRESENTATION AND LONG-TERM IMPLICATIONS OF MALNUTRITION AND FAT-SOLUBLE VITAMIN DEFICIENCIES IN CHILDREN WITH CHOLESTATIC LIVER DISORDERS, BECOME ACQUAINTED WITH DIFFERENCES AMONG THE CURRENTLY AVAILABLE FORMULATION TO SUPPORT NUTRITION IN CHOLESTATIC BABIES, AND THE CURRENTLY AVAILABLE VITAMIN SUPPLEMENTS AND FORMULATIONS. THE LACK OF INSURANCE COVERAGE FOR MEDICAL FOOD AND VITAMINS IS ALSO DISCUSSED.

  • CHILDREN WITH CHOLESTATIC LIVER DISEASE: DIAGNOSTICSCHOLESTATIC JAUNDICE IS A RARE PRESENTATION OF VARIOUS HEPATOBILIARY, METABOLIC, AND GENETIC DISORDERS. CHOLESTASIS TYPICALLY PRESENTS IN THE NEONATAL/INFANTILE PERIOD BUT CAN ALSO PRESENT LATE IN OLDER CHILDREN OR EVEN ADULTS. EARLY DIAGNOSIS AND APPROPRIATE MANAGEMENT OF THE UNDERLYING CONDITION ARE OF PARAMOUNT IMPORTANCE FOR OPTIMAL PROGNOSIS. DIAGNOSIS OF CHOLESTASIS NEEDS AN ARRAY OF INVESTIGATIONS INCLUDING BLOOD TESTS, IMAGING, GENETIC TESTING, AND INVASIVE PROCEDURES LIKE LIVER BIOPSY. LIVER BIOPSY IS ONE OF THE CENTRAL CRUCIAL INVESTIGATIONS DONE IN EVALUATING CHILDREN WITH CHOLESTASIS, HOWEVER, CAN BE ASSOCIATED WITH COMPLICATIONS INCLUDING BLEEDING. UNDERSTANDING WHEN TO USE A LIVER BIOPSY IN CHILDREN WITH CHOLESTASIS ALONG WITH ITS LIMITATIONS IS EXTREMELY IMPORTANT TO GAIN THE MAXIMUM BENEFIT OUT OF AN INVASIVE PROCEDURE. OVER THE LAST DECADE, THE GROWTH IN GENETIC TECHNIQUES AND THE IDENTIFICATION OF NEW GENES LEADING TO CHOLESTASIS IN CHILDREN HAVE EVOLVED SIGNIFICANTLY AND HAVE LED TO THE SHRINKING OF THE UNIDENTIFIED ETIOLOGIES. THIS WEBINAR ADDRESSES THE RAPIDLY EVOLVING FIELD OF GENETIC CHOLESTASIS AND WHEN TO PERFORM A LIVER BIOPSY, ITS UTILITY, AND LIMITATIONS. MEDICAL MANAGEMENT OF CHRONIC PANCREATITIS IN CHILDREN: MAXIMIZING TREATMENT AND IMPROVING OUTCOMESCHRONIC PANCREATITIS (CP) IN CHILDREN IS ASSOCIATED WITH SIGNIFICANT MORBIDITY AND POOR QUALITY OF LIFE. THE INCIDENCE OF CP IN CHILDREN HAS RISEN OVER THE PAST FEW DECADES AND IS APPROACHING THAT SEEN IN THE ADULT POPULATION. CP IS AN INFLAMMATORY DISEASE RESULTING IN IRREVERSIBLE CHANGES IN THE PANCREAS INCLUDING ACINAR CELL LOSS, FIBROSIS, DUCTAL CHANGES, AND CALCIFICATIONS. PATIENTS WITH CP MAY SUFFER FROM ABDOMINAL PAIN AND COMPLICATIONS OF EXOCRINE PANCREATIC INSUFFICIENCY (EPI) AND DIABETES MELLITUS. MEDICAL MANAGEMENT OF CHRONIC PANCREATITIS IN CHILDREN: MAXIMIZING TREATMENT AND IMPROVING OUTCOMES BRINGS TOGETHER LEADING EXPERTS TO DISCUSS HOW TO ENSURE THAT CHILDHOOD CP IS RECOGNIZED EARLY AND ITS SEQUALAE TREATED PROMPTLY.

  • REMOVING DIETING FROM DIET THERAPIES IN PEDIATRIC GIOBESITY WAS DECLARED AN EPIDEMIC BY THE CDC IN THE 1990S, YET SIGNIFICANT AND SUSTAINED WEIGHT LOSS CONTINUES TO BE PROBLEMATIC FOR AMERICANS AS A POPULATION. CRITICAL FACTORS ARE OFTEN OVERLOOKED WHEN ADDRESSING OBESITY SUCH AS RACIAL DISCRIMINATION, DISABILITY STATUS, AND ENVIRONMENTAL FACTORS. IN CONJUNCTION, "WEIGHT STIGMA", OR BIAS THAT DEVALUES PEOPLE WITH LARGER BODIES, CAN CAUSE INCREASED MORBIDITY AND MORTALITY, INDEPENDENT OF BMI. AS A RESPONSE, A MOVEMENT IS TAKING PLACE, KNOWN BY SEVERAL NAMES INCLUDING "ANTI-DIET OR "INTUITIVE EATING". THIS IS AN INCLUSIVE MOVEMENT THAT RECOGNIZES ONE'S SIZE AS PART OF HIS OR HER IDENTITY AS MUCH AS RACE, NATIONAL ORIGIN, AND SEXUALITY. IT CONSIDERS SOCIAL, ECONOMIC, AND PHYSICAL BARRIERS TO OBESITY, RATHER THAN ASSUMING LACK OF WILLPOWER OR EDUCATION ARE THE CAUSE. IT'S ABOUT RECOGNIZING "DIET CULTURE AND DISMANTLING THE ANTI-FAT AND PRO-THIN MESSAGES THAT INFILTRATE SOCIETY. THIS INFORMATIVE AND INTERACTIVE WEBINAR HELPS HEALTHCARE PROVIDERS RECOGNIZE WEIGHT STIGMA AND PROMOTE A POSITIVE RELATIONSHIP WITH FOOD, PARTICULARLY IN PATIENTS WITH GI-RELATED HEALTH CONDITIONS AND THOSE FOLLOWING THERAPEUTIC DIETS.

  • THE WHAT, HOW AND IFS OF OPTIMIZING EARLY CHILDHOOD GROWTH AND LONG-TERM OUTCOMES: PART ONEUNDERSTANDING NORMAL GROWTH AND DEVELOPMENT IS CRITICALLY ESSENTIAL FOR QUICK RECOGNITION AND INTERVENTION FOR DEVIATIONS IN CHILDHOOD GROWTH AND NUTRIENT INTAKE PRACTICES ASSOCIATED WITH INCREASED RISK FOR DISEASE AND POOR LONG-TERM HEALTH. NUTRIENT AND NON-NUTRIENT FACTORS INFLUENCE HEALTH OUTCOMES THROUGHOUT THE LIFECYCLE. THIS WEBINAR AND PODCAST SERIES, THE WHAT, HOW AND IFS OF OPTIMIZING EARLY CHILDHOOD GROWTH AND LONG-TERM OUTCOMES DISCUSSES HOW TO IMPLEMENT NUTRIENT AND NON-NUTRIENT FACTORS THAT OPTIMIZE LONG-TERM HEALTH, RECOGNIZE CHILDHOOD GROWTH AND NUTRIENT INTAKE PATTERNS ASSOCIATED WITH DISEASE, CHILDHOOD MICROBIOME AND LONG-TERM RISK FOR DISEASE, AND EARLY DIAGNOSIS AND MANAGEMENT STRATEGIES FOR CHILDHOOD FEEDING DISORDERS.THE WHAT, HOW AND IFS OF OPTIMIZING EARLY CHILDHOOD GROWTH AND LONG-TERM OUTCOMES: PART TWOUNDERSTANDING NORMAL CHILDHOOD GROWTH IS ESSENTIAL FOR QUICK RECOGNITION AND INTERVENTION FOR DEVIATIONS IN GROWTH AND NUTRIENT INTAKE ASSOCIATED WITH LONG-TERM RISK FOR DISEASE AND POOR HEALTH. THEREFORE, THE 'WHAT, HOW, AND IFS OF OPTIMIZING CHILDHOOD GROWTH AND LONG-TERM OUTCOMES' WEBINAR SERIES ADDRESSES THE KNOWLEDGE AND PRACTICE GAPS ABOUT NUTRIENT AND NON-NUTRIENT FACTORS ESSENTIAL FOR OPTIMIZING LONG-TERM HEALTH OUTCOMES. THE FIRST WEBINAR ADDRESSES THE EARLY LIFE NUTRITIONAL FACTORS THAT PROMOTE HEALTHY GROWTH, THE DEVELOPMENT OF A MICROBIOME ASSOCIATED WITH OPTIMIZED LONG-TERM HEALTH, AND THE RECOGNITION OF EARLY CHILDHOOD GROWTH PATTERNS RELATED TO LONG-TERM RISK FOR OVERWEIGHT AND OBESITY. THIS PART TWO WEBINAR FOCUSES ON A NUTRITIONAL ASSESSMENT APPROACH THAT QUICKLY RECOGNIZES DISEASE, NUTRITIONAL MANAGEMENT OF CHILDHOOD FEEDING DISORDERS, AND PRINCIPLES AND STRATEGIES FOR WEANING CHILDREN FROM DEPENDENCE ON TUBE FEEDS.CHILDREN WITH CHOLESTATIC LIVER DISEASE: PRURITIS MANAGEMENTPRURITUS IS A COMMON COMPLICATION OF CHOLESTATIC LIVER DISEASE THAT CAN SIGNIFICANTLY IMPAIR QUALITY OF LIFE. INTRACTABLE PRURITUS IS AN INDICATION FOR LIVER TRANSPLANT REGARDLESS OF PELD/MELD SCORE. THE PATHOPHYSIOLOGY OF PRURITUS IS COMPLEX. SEVERAL MEDICATIONS SERVE AS STANDARDS FOR TREATMENT AND RECENT ADVANCES IN QUANTIFICATION HAS ALLOWED FOR RIGOROUS AND CONTROLLED STUDY OF NEW MEDICATIONS. IN CERTAIN CIRCUMSTANCES, LIVER TRANSPLANT CAN BE AVOIDED OR DELAYED WITH SURGICAL BILIARY INTERVENTION.NASPGHAN FELLOWS TOOLBOX WEBSITETHE NASPGHAN TOOLBOX WEBSITE IS DESIGNED TO DELIVER PEDIATRIC GASTROENTEROLOGY INFORMATION TO CARE PROVIDERS IN A FORMAT THAT IS USER FRIENDLY. THE TOOLBOX PROVIDES EASY ACCESS TO CLINICAL GUIDELINES FOR PEDIATRIC GASTROENTEROLOGISTS AND TRAINEES AND IS NOW AVAILABLE AS A DISTINCT WEBSITE LINKED FROM THE NASPGHAN WEBSITE. FEATURES OF THE TOOLBOX INCLUDE ALGORITHMS TO NAVIGATE CLINICAL GUIDELINES FOR VARIOUS DISEASES; HIGH QUALITY IMAGES OF GI PATHOLOGY; HELPFUL TABLES ON MANAGING NUTRITIONAL NEEDS; SCORES AND CALCULATORS TO ASSIST IN CALCULATING IMPORTANT PEDIATRIC GI SCORES; AND A CONVENIENT SEARCH FEATURE.JUNIOR FACULTY CONFERENCE (DECEMBER 2022)NASPGHAN AND THE NASPGHAN ORGANIZED A STAND-ALONE CONFERENCE DEVOTED TO THE CAREER AND PROFESSIONAL DEVELOPMENT OF OUR MEMBERS AT A JUNIOR LEVEL IN THEIR PROFESSIONAL CAREER; I.E. 2 TO 7 YEARS OUT OF FELLOWSHIP TRAINING. THIS CONFERENCE ADDRESSES ONGOING PROFESSIONAL DEVELOPMENT FOR MEMBERS AT THE JUNIOR LEVEL OF THEIR CAREER, CONTINUE TO NURTURE AND AUGMENT EXISTING AND NEW PROFESSIONAL RELATIONSHIPS AND COLLABORATION, AND COVER SUCH TOPICS AS EXPANDING SELF-AWARENESS AND PERSONAL LEADERSHIP STYLES, IMPROVING COMMUNICATION, DIVERSITY AND INCLUSION, INCREASING FINANCIAL ACUMEN AND STRATEGIC PLANNING, NEGOTIATION STRATEGIES, AND MORE.BOWEL SOUNDS EPISODES ON EARLY NUTRITIONBOWEL SOUNDS IS A PODCAST ON ALL THINGS RELATED TO PEDIATRIC GASTROENTEROLOGY, HEPATOLOGY, AND NUTRITION. EPISODES FEATURE INTERVIEWS WITH EXPERTS OFFERING CLINICAL AND ACADEMIC PEARLS AND CAREER ADVICE WITH SOMETHING FOR EVERYONE REGARDLESS OF CAREER STAGE OR DISCIPLINE. NEW EPISODES ARE RELEASED EVERY OTHER MONDAY. TWO BOWEL SOUNDS EPISODES WHICH FOCUS ON EARLY CHILDHOOD NUTRITION INCLUDE: EARLY LIFE NUTRITION AND IMPACT ON CHILDHOOD DEVELOPMENT AND THE ROLE OF THE MICROBIOME IN HEALTHY INFANT AND EARLY CHILDHOOD NUTRITION.

As filed on the 2022 return. The filer continues this part on Schedule O, which is not shown here. A text marked withheld matched a screen for wording that may name a private individual, such as an honorific or "in memory of". Most of what it withholds names no one; it is withheld so that what does is never shown.

Listed in Part VII

  • Menno Verhave MD

    PAST PRESIDENT

    Total calculated
    $0
    Hours/week
    1
  • Barry Wershil MD

    PAST PRESIDENT

    Total calculated
    $0
    Hours/week
    1
  • Ann Scheimann MD MBA

    PRESIDENT

    Total calculated
    $0
    Hours/week
    1
  • Praveen Goday MD

    DIRECTOR

    Total calculated
    $0
    Hours/week
    0.5
  • Benjamin Gold MD

    DIRECTOR

    Total calculated
    $0
    Hours/week
    0.5 + 3 related
  • Jeannie Huang MD MPH

    SECRETARY-TREASURER

    Total calculated
    $0
    Hours/week
    0.5
  • Marjorie Merrick

    DIRECTOR

    Total calculated
    $0
    Hours/week
    0.5
  • Karen Murray MD

    DIRECTOR

    Total calculated
    $0
    Hours/week
    0.5 + 0.5 related
  • Vicky Ng MD

    DIRECTOR

    Total calculated
    $0
    Hours/week
    0.5
  • Patricia Robuck PhD MPH

    DIRECTOR

    Total calculated
    $0
    Hours/week
    0.5
  • Joel Rosh MD

    DIRECTOR

    Total calculated
    $0
    Hours/week
    0.5
  • Robert Dahms

    DIRECTOR

    Total calculated
    $0
    Hours/week
    0.5
  • Margaret Stallings

    EXECUTIVE DIRECTOR

    Total calculated
    $247,035
    From this org
    $50,000
    From related orgs
    $193,117
    Other
    $3,918
    Hours/week
    6 + 37 related

    Schedule J breakdown matched by us

    Base
    $50,000 + $193,117 related
    Bonus
    $0
    Other
    $0
    Deferred
    $0
    Nontaxable benefits
    $0 + $3,918 related
    Filer's total
    $50,000 + $197,035 related

Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those. A Schedule J breakdown is as filed: base pay, bonus, other, deferred compensation and nontaxable benefits from this organization, with any from related organizations beside each, and the filer's own total. It is shown with the Part VII listing of the same name on the same return. The form gives no key between the two, so that pairing is ours, and is marked matched by us.

Schedule J

Answered yes

  • 3 · Compensation committee
  • 3 · Compensation survey or study
  • 3 · Approval by the board or compensation committee

Answered no

  • 4a · Severance or change-of-control payment
  • 4b · Supplemental nonqualified retirement plan
  • 4c · Equity-based compensation arrangement
  • 5a · Pay contingent on this organization's revenues
  • 5b · Pay contingent on a related organization's revenues
  • 6a · Pay contingent on this organization's net earnings
  • 6b · Pay contingent on a related organization's net earnings
  • 7 · Other non-fixed payments
  • 8 · Paid under the initial-contract exception

The filer's explanations (Part III)

PART I, QUESTION 3
THE RELATED ORGANIZATION, NORTH AMERICAN SOCIETY FOR PEDIATRIC GASTROENTEROLOGY HEPATOLOGY AND NUTRITION (NASPGHAN), DETERMINES THE COMPENSATION FOR THE FOUNDATION'S EXECUTIVE DIRECTOR. NASPGHAN'S PROCESS FOR DETERMINING COMPENSATION INCLUDES THE REVIEW OF SIMILAR SOCIETIES AND AN ANNUAL EVALUATION.

Part I's answers as filed. A line not listed was left unanswered; on lines 1a and 3 that means the box was not checked.

Grants on this return

Related organizations on this return

Schedule R Part II: tax-exempt organizations related to the filer by control. It does not record shared board members or money.

Provenance

Return type
form_990
Tax year
2022
Filed
15 November 2023
IRS schema version
2022v5.0
Source object
202343209349300914

Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.

The source document this was parsed from is served over the API, which is where bulk and document access live.